These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16263355)

  • 21. [Drug-eluting or bare-metal stents in interventional cardiology. Theory and practice].
    Er F; Erdmann E
    Med Klin (Munich); 2007 Jan; 102(1):30-2. PubMed ID: 17221349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restenosis in percutaneous coronary intervention--is drug-eluting stent the answer?
    Lim VY; Lim YL
    Singapore Med J; 2003 Sep; 44(9):482-7. PubMed ID: 14740779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-eluting stent restenosis the pattern predicts the outcome.
    Cosgrave J; Melzi G; Biondi-Zoccai GG; Airoldi F; Chieffo A; Sangiorgi GM; Montorfano M; Michev I; Carlino M; Bonizzoni E; Colombo A
    J Am Coll Cardiol; 2006 Jun; 47(12):2399-404. PubMed ID: 16781366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-eluting stents show delayed healing: paclitaxel more pronounced than sirolimus.
    van Beusekom HM; Saia F; Zindler JD; Lemos PA; Swager-Ten Hoor SL; van Leeuwen MA; de Feijter PJ; Serruys PW; van der Giessen WJ
    Eur Heart J; 2007 Apr; 28(8):974-9. PubMed ID: 17434882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Status of drug-eluting coronary stents.
    Chodosh A; Korr KS; Burtt D
    Med Health R I; 2008 Oct; 91(10):309-12, 314. PubMed ID: 19044106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of patients with in-stent restenosis.
    Alfonso F; Pérez-Vizcayno MJ; Cruz A; García J; Jimenez-Quevedo P; Escaned J; Hernandez R
    EuroIntervention; 2009 May; 5 Suppl D():D70-8. PubMed ID: 19736076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravascular brachytherapy versus drug-eluting stents for the treatment of patients with drug-eluting stent restenosis.
    Torguson R; Sabate M; Deible R; Smith K; Chu WW; Kent KM; Pichard AD; Suddath WO; Satler LF; Waksman R
    Am J Cardiol; 2006 Nov; 98(10):1340-4. PubMed ID: 17134625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repeated drug-eluting stent implantation for drug-eluting stent restenosis: the same or a different stent.
    Cosgrave J; Melzi G; Corbett S; Biondi-Zoccai GG; Babic R; Airoldi F; Chieffo A; Sangiorgi GM; Montorfano M; Michev I; Carlino M; Colombo A
    Am Heart J; 2007 Mar; 153(3):354-9. PubMed ID: 17307411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of sirolimus-eluting stent, paclitaxel-eluting stent, and bare metal stent in the treatment of long coronary lesions.
    Kim YH; Park SW; Lee CW; Hong MK; Gwon HC; Jang Y; Lee MM; Koo BK; Oh DJ; Seung KB; Tahk SJ; Yoon J; Park SJ
    Catheter Cardiovasc Interv; 2006 Feb; 67(2):181-7. PubMed ID: 16400663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Head-to-head comparison of sirolimus- and paclitaxel-eluting stent in the same diabetic patient with multiple coronary artery lesions: a prospective, randomized, multicenter study.
    Tomai F; Reimers B; De Luca L; Galassi AR; Gaspardone A; Ghini AS; Ferrero V; Favero L; Gioffrè G; Prati F; Tamburino C; Ribichini F
    Diabetes Care; 2008 Jan; 31(1):15-9. PubMed ID: 17909090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus 2-year clinical outcomes of the DES-DIABETES trial.
    Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Hong MK; Rhee KS; Chae JK; Ko JK; Park JH; Lee JH; Choi SW; Jeong JO; Seong IW; Cho YH; Lee NH; Kim JH; Chun KJ; Kim HS; Park SJ
    J Am Coll Cardiol; 2009 Mar; 53(9):812-3. PubMed ID: 19245976
    [No Abstract]   [Full Text] [Related]  

  • 32. Intracoronary radiation therapy for multi-drug resistant in-stent restenosis: initial clinical experience.
    Price MJ; Giap H; Teirstein PS
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):132-4. PubMed ID: 17139654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of restenosis after placement of drug-eluting stents in one or more coronary arteries.
    Lee CW; Park DW; Lee BK; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2006 Feb; 97(4):506-11. PubMed ID: 16461047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of significant chronic kidney disease on long-term clinical outcomes after drug-eluting stent versus bare metal stent implantation.
    Jeong YH; Hong MK; Lee CW; Park DW; Kim YH; Kim JJ; Park SW; Park SJ
    Int J Cardiol; 2008 Mar; 125(1):36-40. PubMed ID: 17521753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Everolimus- and zotarolimus-eluting stents for bare metal stent in-stent restenosis treatment: a prospective study.
    Toutouzas K; Patsa C; Tsiamis E; Tsioufis C; Spanos A; Stefanadi E; Tentolouris C; Stefanadis C
    J Interv Cardiol; 2008 Oct; 21(5):388-94. PubMed ID: 18705639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Very late [corrected] thrombosis of a sirolimus-eluting stent.
    Henderson D; Gunalingam B
    Catheter Cardiovasc Interv; 2006 Sep; 68(3):406-8. PubMed ID: 16892439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.
    Steinberg DH; Gaglia MA; Pinto Slottow TL; Roy P; Bonello L; De Labriolle A; Lemesle G; Torguson R; Kineshige K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2009 Feb; 103(4):491-5. PubMed ID: 19195508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical evidence on polymer-based sirolimus and paclitaxel eluting stents.
    Iijima R; Mehilli J; Schömig A; Kastrati A
    Minerva Cardioangiol; 2006 Oct; 54(5):539-55. PubMed ID: 17019392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
    Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized trial of a nonpolymer-based rapamycin-eluting stent versus a polymer-based paclitaxel-eluting stent for the reduction of late lumen loss.
    Mehilli J; Kastrati A; Wessely R; Dibra A; Hausleiter J; Jaschke B; Dirschinger J; Schömig A;
    Circulation; 2006 Jan; 113(2):273-9. PubMed ID: 16391155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.